Also, we found that decrease of tumor progression was related to the PI3K/AKT and Raf/MEK/ERK pathways which are responsible for glioma growth, invasiveness, chemo- and radiotherapy resistance, and recurrence [11, 13]. This evidence concerns the gene AKT1 and neoplasm.